Get the Stockscreener App
3.6215
1.93%
-0.0785
Cargo Therapeutics Inc stock is traded at $3.6215, with a volume of 559.30K.
It is down -1.93% in the last 24 hours and down -75.47% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
See More
Previous Close:
$3.70
Open:
$3.71
24h Volume:
559.30K
Relative Volume:
0.79
Market Cap:
$170.30M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-1.01
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
+0.80%
1M Performance:
-75.47%
6M Performance:
-73.78%
1Y Performance:
-84.22%
1-Day Range:
$3.56
$3.80
1-Week Range:
$3.44
$3.93
52-Week Range:
$3.00
$33.92
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
3.62 | 170.30M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.85 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.03 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
650.78 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
274.88 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.75 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-30-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-30-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Jan-30-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-30-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-30-25 | Downgrade | Truist | Buy → Hold |
| Jan-30-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
Evaluating the Ups and Downs of CARGO Therapeutics Inc’s (CRGX) Stock - The News Heater
Research Analysts Set Expectations for CRGX Q1 Earnings - MarketBeat
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - Longview News-Journal
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Connect - Markets Insider
CARGO Therapeutics (NASDAQ:CRGX) Hits New 52-Week LowTime to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CARGO Therapeutics, Inc. (CRGX) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Did CARGO Therapeutics Inc (CRGX) perform well in the last session? - US Post News
Closing Bell Recap: CARGO Therapeutics Inc (CRGX) Ends at 3.65, Reflecting a 1.39 Upturn - The Dwinnex
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by Truist Financial - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Cut to Neutral at Chardan Capital - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Neutral at HC Wainwright - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by William Blair - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Hold at Jefferies Financial Group - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Downgraded to "Neutral" Rating by Piper Sandler - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Lowered to "Underweight" Rating by JPMorgan Chase & Co. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Investors to Inquire about Securities Investigation - Markets Insider
CARGO Therapeutics, Inc. (CRGX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
CARGO Therapeutics stock hits 52-week low at $3.12 - MSN
Cargo Therapeutics stock tumbles after trial setback - MSN
HC Wainwright Expects Higher Earnings for CARGO Therapeutics - Defense World
William Blair Has Optimistic Outlook of CRGX Q1 Earnings - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Reach Out - Markets Insider
CARGO Therapeutics (NASDAQ:CRGX) Sets New 1-Year Low – Here’s What Happened - Defense World
Stock summary: CARGO Therapeutics reflected weekly fall of 73.11% - Business Upturn
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Underweight at JPMorgan Chase & Co. - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by Chardan Capital - Defense World
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why - NewsBreak
CARGO Thera tanks as it halts FIRCE-1 Phase II study of firi-cel - The Pharma Letter
JPMorgan Chase & Co. Acquires 6,426 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Where are the Opportunities in (CRGX) - Stock Traders Daily
HC Wainwright & Co. Downgrades CARGO Therapeutics (CRGX) - MSN
Cargo Therapeutics stock rating cut by Jefferies to Hold - Investing.com Canada
Truist Securities Downgrades CARGO Therapeutics (CRGX) - MSN
Chardan cuts Cargo Therapeutics stock rating to neutral - MSN
Market Shocks: Crown Electrokinetics, China Liberal Education, and CARGO Therapeutics Plummet, While Foxx Development and Alpha Modus Skyrocket – Market - HPBL
Stock Market Movers: FOXX and AMOD Surge While CRGX and CRKN Face Sharp Declines - HPBL
Bay Area biotech firm guts staff, shuts trial after dangerous side effects - SFGATE
Chardan Capital Downgrades CARGO Therapeutics (CRGX) - MSN
CARGO Therapeutics, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsCRGX - PR Newswire
JPMorgan cuts Cargo Therapeutics stock rating to Underweight - MSN
Piper Sandler cuts Cargo Therapeutics rating to neutral - MSN
CARGO Therapeutics stock hits 52-week low at $3.12 By Investing.com - Investing.com Australia
Stock market news: Crown Electrokinetics -99.50%, CARGO Therapeutics -74.34% among biggest losers during mid day trading - Business Upturn
JPMorgan cuts Cargo Therapeutics stock rating to Underweight By Investing.com - Investing.com Canada
Peninsula biotech moves from IPO to chopping half its workforce in little more than a year - The Business Journals
Piper Sandler cuts Cargo Therapeutics rating to neutral By Investing.com - Investing.com Australia
Stock market today: Aclarion -99.69%, CARGO Therapeutics -76.31% among biggest losers in early trading - Business Upturn
Dow Jumps Over 100 Points; Tesla Earnings Miss Views - Benzinga
Cargo to drop lead CAR-T therapy, lay off staff after study setback - BioPharma Dive
Truist cuts Cargo Therapeutics rating, slashes PT to $7 By Investing.com - Investing.com Australia
This Everest Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cargo Therapeutics Inc Stock (CRGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chapman Gina | President & CEO |
Sep 19 '24 |
Option Exercise |
5.03 |
2,975 |
14,964 |
106,880 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Sale |
25.09 |
7,166 |
179,775 |
103,905 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Sale |
25.03 |
2,975 |
74,457 |
103,905 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Option Exercise |
5.03 |
1,600 |
8,048 |
8,046 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Sale |
25.28 |
1,600 |
40,452 |
6,446 |
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):